Compagnie Lombard Odier SCmA’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-92
| Closed | -$5K | – | 634 |
|
|
2021
Q4 | $5K | Hold |
92
| – | – | ﹤0.01% | 643 |
|
|
2021
Q3 | $8K | Hold |
92
| – | – | ﹤0.01% | 597 |
|
|
2021
Q2 | $10K | Hold |
92
| – | – | ﹤0.01% | 579 |
|
|
2021
Q1 | $10K | Buy |
+92
| New | +$10K | ﹤0.01% | 598 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 545 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 559 |
|
|
2017
Q3 | – | Sell |
-167
| Closed | -$16K | – | 684 |
|
|
2017
Q2 | $16K | Hold |
167
| – | – | ﹤0.01% | 624 |
|
|
2017
Q1 | $13K | Hold |
167
| – | – | ﹤0.01% | 655 |
|
|
2016
Q4 | $14K | Hold |
167
| – | – | ﹤0.01% | 728 |
|
|
2016
Q3 | $19K | Hold |
167
| – | – | ﹤0.01% | 789 |
|
|
2016
Q2 | $18K | Sell |
167
-200
| -54% | -$21.6K | ﹤0.01% | 785 |
|
|
2016
Q1 | $38K | Buy |
367
+125
| +52% | +$12.9K | ﹤0.01% | 752 |
|
|
2015
Q4 | $19K | Buy |
+242
| New | +$19K | ﹤0.01% | 800 |
|
|
2014
Q1 | – | Sell |
-177
| Closed | -$25K | – | 882 |
|
|
2013
Q4 | $25K | Buy |
+177
| New | +$25K | ﹤0.01% | 765 |
|